You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Amgen Inc. (AMGN $280.10)
- $280.10 P/E (TTM): 23.19X Cap: $150.79B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $567.22)
- $567.22 P/E (TTM): 14.19X Cap: $60.11B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $396.93)
- $396.93 P/E (TTM): 28.11X Cap: $101.76B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $140.35)
- $140.35 P/E (TTM): 18.86X Cap: $5.62B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,287.79)
- $1,287.79 P/E (TTM): 32.17X Cap: $26.52B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $5.56)
- $5.56 Cap: $447M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $4.94)
- $4.94 Cap: $13M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022

Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use